Own and execute DELFI's U.S. market access and reimbursement strategy across product lines, from coding and coverage through payment.

Serve as DELFI's subject-matter expert on CMS/Medicare, including Medicare Administrative Contractors, LCD/NCD processes, MolDX, and the ADLT, gapfill, and crosswalk pricing pathways relevant to novel diagnostics.

Develop and drive coverage strategies with priority payers, including Medicare, regional and integrated payers, and the VA.

Build formal strategic reimbursement plans for new product launches, including evaluation of coding, coverage, and payment options and innovative alternative payment models.

Partner cross-functionally with Medical Affairs, Clinical, Commercial, Regulatory, and Health Economics to align evidence generation with payer requirements and minimize utilization-management restrictions.

Partner with Legal/Compliance to ensure all engagement with payers, professional societies and KOLs complies with applicable law and industry codes, maintaining a clear distinction between non-promotional scientific exchange and commercial/reimbursement activity. 

Identify health-economic evidence gaps and translate payer evidence needs into cross-functional study and dossier requirements.

Engage external stakeholders, including payers, health technology assessment bodies, professional societies, and KOLs, to shape favorable coverage policy in coordination with Commercial leadership on downstream adoption and utilization. 

Establish the foundational tools, processes, and consultant and advisor network for a scalable market access function, and build the team as the function grows.